SCHEMBL28059164

SCHEMBL28059164

O=C(CP(C1CCCCC1)C1CCCCC1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.44
KMT2A Q03164 6/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MAPT P10636 3/20 0.44
MAPK1 P28482 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
HPGD P15428 2/20 0.44
MEN1 O00255 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
CES1 P23141 1/20 0.44
GAA P10253 2/20 0.43
RAB9A P51151 2/20 0.43
HTT P42858 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ALDH1A1 P00352 7/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
GFER P55789 1/20 0.41
GSK3B P49841 2/20 0.41
TRPA1 O75762 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28080856 0.94 KDM4E (0.40) KDM4EKMT2ASMN1; SMN2MAPTMAPK1
Ethylene SCHEMBL28200918 0.91 KDM4E (0.39) KDM4EKMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL6061540 0.73 ALDH1A1 (0.36) KDM4ESMN1; SMN2MAPTCYP3A4CES1
SCHEMBL28595923 0.73 EPHX2 (0.57) KDM4EKMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL20955841 0.73 MCL1 (0.43) KDM4ESMN1; SMN2HPGDCES1GAA
SCHEMBL1278317 0.73 EPHX2 (0.57) KDM4EKMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL2438485 0.73 EPHX2 (0.57) KDM4EKMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL7094216 0.73 EPHX2 (0.57) KDM4EKMT2ASMN1; SMN2MAPTMAPK1
SCHEMBL28414399 0.71 MCL1 (0.42) KDM4EKMT2ASMN1; SMN2HPGDMEN1
SCHEMBL28468123 0.71 MAPK1 (0.61) KDM4EKMT2ASMN1; SMN2MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105407892-A Pharmaceutical compositions of 7- (6- (2-hydroxypropan-2-yl) pyridin-3-yl) -1- ((trans) -4-methoxycyclohexyl) -3, 4-dihydropyrazino [2,3-B ] pyrazin-2 (1H) -one, solid forms thereof, and methods of their use SIGNAL PHARM LLC 2016-03-16 CN claimed
CN-105407892-B Pharmaceutical composition of compound, solid form thereof and methods of use thereof 西格诺药品有限公司 2019-05-07 CN disclosed
CN-105407892-A Pharmaceutical compositions of 7- (6- (2-hydroxypropan-2-yl) pyridin-3-yl) -1- ((trans) -4-methoxycyclohexyl) -3, 4-dihydropyrazino [2,3-B ] pyrazin-2 (1H) -one, solid forms thereof, and methods of their use SIGNAL PHARM LLC 2016-03-16 CN disclosed